Weekly AI digest
Radiology & medical imaging AI · week of 11 to 17 October 2026
228 peer-reviewed papers · 4 industry and regulatory items · conference and KOL highlights. Adapted from my weekly intelligence report. Full report: FR (PDF) · EN (PDF) · RU (PDF).
Governance takeaway
What to do about it this week
Validate the use, not the tool. This week the same mammography AI swung from modest to large gains depending on how it was wired into the read; adult chest models failed on neonates until they were adapted with 50 local radiographs per site; and the largest prostate MRI AI study to date matched radiologists on average while leaving 28% of sites below an AUC of 0.80.
For every deployed model, write a single line naming the integration policy, who sees the output and when it can override, and the patient and reader population your acceptance test actually covered. Treat any use outside that line, a new scenario, a new population, a new site, as a new deployment that needs its own acceptance test and monitoring baseline.
Regulation & AI Act watch
SimBioSys TumorSight Risk cleared as first MRI-derived breast cancer recurrence prognostic
FDA 510(k) clearance as a prognostic indicator of recurrence-free survival at five and ten years in HR-positive, HER2-negative stage I to IIIA breast cancer, from routine MRI, pathology and clinical data; evidence is vendor-cited, a multicenter ASCO 2026 study of over 2,100 patients, with no peer-reviewed validation in the release. First question for the vendor: what does the score add to the genomic assays already guiding the same decisions, in a cohort that looks like yours.Thirona LungQ MP CE-certified Class IIb for automated mucus plug analysis
CE marking under EU MDR for fully automated quantification of airway-occluding mucus plugs on chest CT, for phenotyping and treatment monitoring. Certification attests conformity, not a published reader study. First question: how reproducible are the counts and volumes across CT vendors, kernels and slice thicknesses.Cortechs.ai brings NeuroQuant suite to the CARPL.ai marketplace
A distribution partnership putting the quantitative neuroimaging portfolio behind CARPL.ai's single integration and procurement channel. Marketplace access lowers integration cost, not the evidence bar. First question: does platform monitoring expose the per-tool, per-site metrics your governance needs, and who holds deployer obligations under the AI Act.Sirona Medical raises $40M Series D for agentic AI in the radiology workflow
Funding to commercialize Cortex, an orchestration layer meant to draft context-aware preliminary interpretations and automate reporting; no clinical performance data accompany the claims. First question: what is the regulatory status of the preliminary-interpretation capability, and how does the platform log which model contributed what to a signed report.
Evidence you can use
Selected from 228 papers indexed in PubMed this week.
Optimizing AI-assisted decision-making in mammography screening: focusing on uncertainties
Insights into Imaging, 13 October 2026Improving Postpolypectomy Surveillance Decisions Using an Automated Analysis of Colonoscopy and Histopathology Reports: 2-Center Validation Study
Journal of Medical Internet Research, 16 October 2026Curriculum-Aligned Conversational AI to Support Pathology Self-Directed Learning in Preclinical Medical Students: A Crossover Randomized Pilot Study
JMIR Medical Education, 13 October 2026Development and External Testing of an Interpretable MRI-Based Machine Learning Model for Differentiating Endometrial Stromal Sarcoma from Cellular Leiomyoma
Journal of Imaging Informatics in Medicine, 13 October 2026Interpretable Source-Aware Bone-Muscle Fusion Framework for Multicenter Prediction of Osteoporotic Vertebral Fractures
Journal of Imaging Informatics in Medicine, 13 October 2026Automated Lewis Score Estimation for Small Bowel Crohn Disease Using Capsule Endoscopy: Retrospective Cohort Study
JMIR Medical Informatics, 13 October 2026Validation of a Deep Learning Model for Automated Ureteral Length Measurement on CT Against Gross Specimens
Journal of Imaging Informatics in Medicine, 13 October 2026Repurposing adult AI radiograph models for neonatal care through continual learning: an international multicentre study
Nature Biomedical Engineering, 13 October 2026
Post-market signal
Two publications this week move post-market surveillance from aspiration toward tooling. In npj Digital Medicine, AEGIS describes an operational infrastructure for governing adaptive medical AI under FDA Predetermined Change Control Plans and EU post-market surveillance: every candidate model update is routed into APPROVE, CONDITIONAL APPROVAL, CLINICAL REVIEW or REJECT, with an independent ALARM state for a released model at risk. On real cross-site data, batch-wise drift detection reached ROC-AUC 1.00 on batches of about 500 patients with no false alarms. It is a proof of concept covering covariate shift only, but the four-outcome taxonomy and the batch-wise drift gate are a usable skeleton for an Article 72 monitoring file today.
A WAIRR explainer published October 14 reads the drift evidence critically rather than reverently. The Grampian mammography analysis shows a manufacturer threshold set elsewhere would have flagged 48.3% of exams against 5.4% for the first human reader, and a scanner software update tripled the flag rate after site calibration. The Mayo Clinic CTPA disagreement monitor shows the asymmetry that matters: a 2 to 3% fall in specificity produced a two to threefold rise in discrepancies, while a 10% sensitivity drop was needed for the same signal. Disagreement monitors catch extra false alarms quickly and missed findings slowly, which is the more dangerous failure to miss.
Playbook snippet
One step for your AI committee
Anchor: EU AI Act Article 14 (human oversight).
Step: Before a new tool goes live, record each reader's baseline on a fixed local case set: reading time plus detection or marking rate. Repeat at 3 months with the tool on and report per-reader deltas, never only the pooled average.
Why: Pooled averages hide what a tool does to specific humans: assistance can lift junior readers, slow senior readers, or move two readers in opposite directions, and oversight is only real if you know which is happening in your reading room.
Worked example: Zhou Y et al. (Journal of Imaging Informatics in Medicine, PMID 42870161, DOI 10.1007/s10278-026-02352-w): with an interpretable MRI model for endometrial stromal sarcoma, the junior radiologist's specificity rose from 46.4% to 82.1%, exactly the per-reader delta an Article 14 oversight file should contain. This week's mammography scenario study (PMID 42867728) makes the same point at policy level: the integration scenario, not the model, produced the gain.
From the field
SIIM's Enterprise Imaging webinar series hosted Sectra on October 14 for a live demonstration of autonomous AI clearing normal chest exams from the worklist, the capability acquired with Oxipit, with the validation and safety thresholds applied before deployment on the agenda. Autonomous normal-clearing is the sharpest test of local validation discipline there is, since no human reads what the model clears.
RSNA published participant feedback on its Imaging AI Certificate Program on October 16: completers report stronger skills in evaluating, implementing and monitoring AI tools, with a Neuroradiology certificate due late 2026. The Journal of Imaging Informatics in Medicine also released its SIIM 2026 abstract supplement, a useful scan of what imaging informatics teams are building under governance, privacy and interoperability constraints.
On LinkedIn, Pranav Rajpurkar announced the Nature Biomedical Engineering study behind this week's flagship selection, 30 neonatal ICUs adapting an adult model with 50 radiographs each, and framed it plainly: newborns are among the patients medical AI serves least. Woojin Kim shared the ACR Data Science Institute's EuSoMII wrap-up, where he presented the ACR's work on imaging AI quality and performance monitoring, including the Assess-AI registry.
Amine Korchi argued that many radiology inefficiencies share one root cause, poor cross-functional understanding between radiologists, technologists and secretaries, and that operational excellence takes designed processes and training, not more individual effort. A reminder that AI lands on top of exactly these processes.
Source articles are indexed in PubMed with verified DOIs. Manuscript-stage work is excluded. The full weekly report is produced in French.
Get the weekly digest
One email a week on what matters in radiology and imaging AI. Researched by a radiologist and imaging informatics professional. Free, no vendor sponsorship.